This record was last updated April 29, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a multicenter, ambidirectional cohort real-world study initiated by the First Affiliated Hospital of Zhengzhou University, aiming to evaluate the efficacy and safety of Pradefovir Mesylate Tablets in the treatment of chronic hepatitis B (CHB).